SCHEMBL8557693

SCHEMBL8557693

N=C(N)NCCCCC(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.56
HTT P42858 1/20 0.52
ALDH1A1 P00352 3/20 0.48
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
HPGD P15428 1/20 0.48
TPSAB1 Q15661 2/20 0.47
TPSD1 Q9BZJ3 2/20 0.47
TPSG1 Q9NRR2 2/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PLG P00747 1/20 0.47
ELANE P08246 1/20 0.47
TGM2 P21980 1/20 0.47
KEAP1 Q14145 1/20 0.45
NFE2L2 Q16236 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8560466 0.96 HTT (0.57) EPHX2HTTALDH1A1KMT2AMEN1
SCHEMBL8174680 0.90 ALDH1A1 (0.51) EPHX2HTTALDH1A1KMT2AMEN1
SCHEMBL20362125 0.88 HTT (0.56) EPHX2HTTTPSAB1TPSD1TPSG1
SCHEMBL21171925 0.86 HTT (0.67) HTTL3MBTL1TGM2KEAP1NFE2L2
SCHEMBL7397242 0.85 HTT (0.52) EPHX2HTTTGM2KEAP1NFE2L2
SCHEMBL24180428 0.84 HTT (0.60) EPHX2HTTALDH1A1KMT2AMEN1
Hydrochloric Acid SCHEMBL9352193 0.83 MEN1 (0.46) EPHX2HTTALDH1A1KMT2AMEN1
Hydrochloric Acid SCHEMBL9352528 0.83 MEN1 (0.46) EPHX2HTTALDH1A1KMT2AMEN1
Hydrochloric Acid SCHEMBL9352205 0.83 MEN1 (0.46) EPHX2HTTALDH1A1KMT2AMEN1
Hydrochloric Acid SCHEMBL9352518 0.83 MEN1 (0.46) EPHX2HTTALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832076-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-04-01 EP disclosed